Neisseria meningitidis group B correlates of protection and assay standardization -: International meeting report Emory University, Atlanta, Georgia, United States, 16-17 march 2005

被引：161

作者：

Borrow, R.

Carlone, G. M.

Rosenstein, N.

Plikaytis, B.

Blake, M.

Feavers, I.

Martin, D.

Zollinger, W.

Robbins, J.

Aaberge, I.

Granoff, D. M.

Miller, E.

van Alphen, L.

Poolman, J.

Rappuoli, R.

Danzig, L.

Hackell, J.

Danve, B.

Caulfield, M.

Lambert, S.

Stephens, D.

机构：

[1] Manchester Royal Infirm, Vaccine Evaluat Unit, Hlth Protect Agcy, Manchester M13 9WZ, Lancs, England

[2] Ctr Dis Control & Prevent, Atlanta, GA USA

[3] US FDA, Bethesda, MD 20014 USA

[4] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England

[5] Inst Environm Sci, Porirua, New Zealand

[6] Walter Reed Army Inst Res, Washington, DC USA

[7] NICHHD, NIH, Bethesda, MD 20892 USA

[8] Norwegian Inst Publ Hlth, NO-0403 Oslo, Norway

[9] Childrens Hosp Oakland, Res Inst, Oakland, CA 94660 USA

[10] Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England

[11] Netherlands Vaccine Inst, NL-3720 AL Bilthoven, Netherlands

[12] GlaxoSmithKline Biol, Rixensart, Belgium

[13] Chiron Vaccines, Siena, Italy

[14] Chiron Vaccines, Emeryville, CA 94608 USA

[15] Wyeth Vaccines, Pearl River, NY 10965 USA

[16] Sanofi Pasteur, F-69280 Marcy Letoile, France

[17] Merck & Co Inc, West Point, PA 19486 USA

[18] WHO, CH-1211 Geneva 27, Switzerland

[19] Emory Univ, Dept Med, Atlanta, GA 30322 USA

来源：

VACCINE | 2006年 / 24卷 / 24期

关键词：

D O I：

10.1016/j.vaccine.2006.03.091

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：5093 / 5107

页数：15

共 101 条

[1] Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic [J].

Aaberge, IS ;

Oster, P ;

Helland, OS ;

Kristoffersen, AC ;

Ypma, E ;

Hoiby, EA ;

Feiring, B ;

Nokleby, H .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (05) :599-605

[2]

ADLAM C, 1987, FEMS MICROBIOL LETT, V42, P23, DOI 10.1111/j.1574-6968.1987.tb02293.x

[3]

Adlam C, 1989, PASTEURELLA PASTEURE, P75

[4] Naturally-acquired immunity to Neisseria miningitidis group A [J].

Amir, J ;

Louie, L ;

Granoff, DM .

VACCINE, 2005, 23 (08) :977-983

[5] VARIABILITY IN THE FUNCTIONAL-ACTIVITY OF VACCINE-INDUCED ANTIBODY TO HAEMOPHILUS-INFLUENZAE TYPE-B [J].

AMIR, J ;

LIANG, XY ;

GRANOFF, DM .

PEDIATRIC RESEARCH, 1990, 27 (04) :358-364

[6] Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England [J].

Andrews, N ;

Borrow, R ;

Miller, E .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) :780-786

[7]

[Anonymous], 2001, OFF J EUR COMMUNITIE

[8]

[Anonymous], 2001, OFFICIAL J EUROPEAN, V311, P67

[9] HUMAN-IMMUNOGLOBULIN-M PARAPROTEINS CROSS-REACTIVE WITH NEISSERIA-MENINGITIDIS GROUP-B POLYSACCHARIDE AND FETAL BRAIN [J].

AZMI, FH ;

LUCAS, AH ;

SPIEGELBERG, HL ;

GRANOFF, DM .

INFECTION AND IMMUNITY, 1995, 63 (05) :1906-1913

[10]

Baker M G, 2001, J Paediatr Child Health, V37, pS13, DOI 10.1046/j.1440-1754.2001.00722.x

← 1 2 3 4 5 6 7 8 9 10 →